Status:

ACTIVE_NOT_RECRUITING

ALHIV Smartphone Game Study

Lead Sponsor:

Emory University

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

Hiv

AIDS

Eligibility:

All Genders

15-21 years

Phase:

NA

Brief Summary

This is a cluster-randomized controlled trial that aims to conduct comprehensive feasibility testing of a smartphone game in a sample of 120 adolescents living with HIV (ALHIV) ages 15-21 in Kisumu, K...

Detailed Description

This is a cluster-randomized feasibility study that will involve clinic-level randomization of 120 ALHIV participants (12 from each of 10 clinical centers). Participants will either use the interventi...

Eligibility Criteria

Inclusion

  • Adolescents, male and female, aged 15-21 in Kisumu County (n=120)
  • Inclusion criteria:
  • Aged 15-21 at time of recruitment
  • Diagnosed with HIV and aware of HIV status
  • Initiated ART at least 6 months prior
  • Accesses HIV-related care at intervention arm CCC
  • VL above 50 copies/ml at last test, with last test conducted within 12 months prior to recruitment date
  • Exclusion criteria
  • Does not have basic literacy in English (Grade 3-4 on the Flesch-Kincaid Reading Scale)
  • Sibling to an adolescent already enrolled in study
  • Sibling to adolescent that participated in formative research
  • Participant in formative research to inform study
  • Participant in any Tumaini game activities
  • Enrolled in boarding school
  • Last recorded viral load test \>12 months prior to recruitment date

Exclusion

    Key Trial Info

    Start Date :

    April 7 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 1 2026

    Estimated Enrollment :

    120 Patients enrolled

    Trial Details

    Trial ID

    NCT06913660

    Start Date

    April 7 2025

    End Date

    July 1 2026

    Last Update

    August 20 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    KEMRI Clinical Research Centre

    Kisumu, Kenya, 54840